Thomas M. Moriarty's Insider Trades & SAST Disclosures
Thomas M. Moriarty's most recent trade in Albertsons Companies Inc - Ordinary Shares - Class A was a trade of 553 Dividend Equivalent Units done . Disclosure was reported to the exchange on May 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas M. Moriarty.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP, M&A and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 553 | 83,464 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP, M&A and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 398 | 60,046 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP, M&A and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 204 | 79,596 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP, M&A and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 185 | 27,953 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP, M&A and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 162 | 82,552 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP, M&A and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 148 | 79,744 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Moriarty Thomas M. | EVP, M&A and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 159,019 | 159,019 | - | - | Time-based Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 82,911 | 82,911 | - | - | Time-based Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 27,637 | 27,637 | - | - | Performance-based Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 27,637 | 27,637 | - | - | Performance-based Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 27,637 | 27,637 | - | - | Performance-based Restricted Stock Units | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Mar 2025 | 3,429 | 0 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.19 per share. | 13 Mar 2025 | 568 | 13,808 (0%) | 0% | 58.2 | 33,052 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 7,075 | 7,075 | - | - | Stock Appreciation Right | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 5,012 | 5,012 | - | - | Restricted Stock Units | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,506 | 2,506 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.27 per share. | 03 Mar 2025 | 571 | 14,544 (0%) | 0% | 57.3 | 32,704 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 571 | 1,143 | - | - | Restricted Stock Units | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.27 per share. | 03 Mar 2025 | 168 | 14,376 (0%) | 0% | 57.3 | 9,622 | Common Stock |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 29,824 | 87,416 | - | - | Time-based Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.55 per share. | 24 Feb 2025 | 29,824 | 59,310 | - | 20.5 | 612,883 | Class A common stock, par value $0.01 per share |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 27,764 | 27,768 | - | - | Time-based Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.55 per share. | 24 Feb 2025 | 27,764 | 42,133 | - | 20.5 | 570,550 | Class A common stock, par value $0.01 per share |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.55 per share. | 24 Feb 2025 | 13,585 | 45,725 | - | 20.6 | 279,172 | Class A common stock, par value $0.01 per share |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.55 per share. | 24 Feb 2025 | 12,647 | 29,486 | - | 20.6 | 259,896 | Class A common stock, par value $0.01 per share |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 62.98 per share. | 21 Feb 2025 | 57 | 4,478 (0%) | 0% | 63.0 | 3,590 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 2,157 | 0 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 1,937 | 13,969 (0%) | 0% | - | Common Stock | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 455 | 455 | - | - | Restricted Stock Units | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.44 per share. | 14 Feb 2025 | 455 | 12,190 (0%) | 0% | 62.4 | 28,408 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.44 per share. | 14 Feb 2025 | 158 | 12,032 (0%) | 0% | 62.4 | 9,865 | Common Stock |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 638 | 89,472 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 396 | 55,532 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 218 | 30,582 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 550 | 88,834 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 341 | 55,136 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 188 | 30,364 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 540 | 88,284 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 335 | 54,795 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 505 | 87,744 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 313 | 54,460 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 173 | 83,240 | - | - | Dividend Equivalent Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 87,239 | 87,239 | - | - | Time-based Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 87,238 | 87,238 | - | - | Performance-based Restricted Stock Units | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.53 per share. | 08 Mar 2024 | 417 | 11,710 (0%) | 0% | 87.5 | 36,500 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 4,685 | 4,685 | - | - | Stock Appreciation Right | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 3,429 | 3,429 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,714 | 1,714 | - | - | Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 27,073 | 54,147 | - | - | Time-based Restricted Stock Units | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 27,073 | 27,073 | - | - | Class A common stock, par value $0.01 per share | |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.44 per share. | 26 Feb 2024 | 12,704 | 14,369 | - | 21.4 | 272,374 | Class A common stock, par value $0.01 per share |
| Stepan Co. | Moriarty Thomas Sean | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 93.91 per share. | 26 Feb 2024 | 34 | 4,337 (0%) | 0% | 93.9 | 3,193 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Feb 2024 | 2,729 | 0 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,940 | 0 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,323 | 12,125 (0%) | 0% | - | Common Stock | |
| Stepan Co. | Thomas Sean Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,304 | 12,106 (0%) | 0% | - | Common Stock | |
| Stepan Co. | Moriarty Sean Thomas | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 455 | 910 | - | - | Restricted Stock Units | |
| Stepan Co. | Moriarty Sean Thomas | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.03 per share. | 14 Feb 2024 | 455 | 10,960 (0%) | 0% | 89.0 | 40,509 | Common Stock |
| Stepan Co. | Sean Moriarty Thomas | VP & GM Surfactants | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.03 per share. | 14 Feb 2024 | 158 | 10,802 (0%) | 0% | 89.0 | 14,067 | Common Stock |
| Albertsons Companies Inc -... | Thomas M. Moriarty | EVP General Counsel & CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 457 | 81,220 | - | - | Dividend Equivalent Units | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.96 per share. | 03 Mar 2023 | 843 | 10,480 (0%) | 0% | 105.0 | 88,485 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 109.87 per share. | 17 Feb 2023 | 90 | 4,233 (0%) | 0% | 109.9 | 9,888 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 3,797 | 3,797 | - | - | Stock Appreciation Right | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 2,875 | 11,321 (0%) | 0% | - | Common Stock | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 2,729 | 2,729 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 1,760 | 0 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 1,365 | 1,365 | - | - | Restricted Stock Units | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.19 per share. | 31 Dec 2022 | 292,856 | 315,273 (0%) | 0% | 93.2 | 27,291,251 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.05 per share. | 15 Dec 2022 | 100,976 | 709,105 (0%) | 0% | 78.1 | 7,881,177 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 98.40 per share. | 15 Dec 2022 | 100,976 | 608,129 (0%) | 0% | 98.4 | 9,936,311 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 100,976 | 24,248 | - | - | Stock Option | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 98.24 per share. | 15 Dec 2022 | 36,490 | 608,129 (0%) | 0% | 98.2 | 3,584,869 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.21 per share. | 15 Dec 2022 | 36,490 | 644,619 (0%) | 0% | 62.2 | 2,270,043 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 36,490 | 0 | - | - | Stock Option | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 28 Jun 2022 | 50,502 | 626,273 (0%) | 0% | 95 | 4,797,690 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.19 per share. | 28 Jun 2022 | 50,502 | 676,775 (0%) | 0% | 54.2 | 2,736,703 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2022 | 50,502 | 50,502 | - | - | Stock Option | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.35 per share. | 28 Jun 2022 | 49,279 | 675,552 (0%) | 0% | 58.4 | 2,875,430 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 28 Jun 2022 | 49,279 | 626,273 (0%) | 0% | 95 | 4,681,505 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2022 | 49,279 | 98,558 | - | - | Stock Option | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 28 Jun 2022 | 38,873 | 626,273 (0%) | 0% | 95 | 3,692,935 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2022 | 38,873 | 116,622 | - | - | Stock Option | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.30 per share. | 28 Jun 2022 | 38,873 | 665,146 (0%) | 0% | 74.3 | 2,888,264 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.09 per share. | 01 Apr 2022 | 105,854 | 730,897 (0%) | 0% | 101.1 | 10,700,781 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 46,777 | 46,777 | - | - | Stock Option | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.09 per share. | 01 Apr 2022 | 3,556 | 735,349 (0%) | 0% | 101.1 | 359,476 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 51,361 | 0 | - | - | Stock Option | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.26 per share. | 15 Mar 2022 | 51,361 | 888,112 (0%) | 0% | 102.3 | 5,252,176 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 15 Mar 2022 | 51,361 | 836,751 (0%) | 0% | 105 | 5,392,905 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.49 per share. | 04 Mar 2022 | 698 | 8,427 (0%) | 0% | 102.5 | 71,538 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2022 | 572,542 | 621,821 (0%) | 0% | 0 | Common Stock | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2022 | 214,930 | 836,751 (0%) | 0% | 0 | Common Stock | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 10,087 | 10,087 | - | - | Stock Appreciation Right | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 2,381 | 9,123 (0%) | 0% | - | Common Stock | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 2,157 | 2,157 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,950 | 0 | - | - | Performance Shares | |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 112.41 per share. | 15 Feb 2022 | 76 | 4,099 (0%) | 0% | 112.4 | 8,543 | Common Stock |
| Stepan Co. | Sean Thomas Moriarty | VP & GM Surfactants | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 12 | 5,448 | - | - | Share Units | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 109,469 | 36,490 | - | - | Stock Option | |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 86.00 per share. | 10 May 2021 | 109,469 | 0 (0%) | 0% | 86 | 9,414,334 | Common Stock |
| CVS Health Corp | Thomas M. Moriarty | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.21 per share. | 10 May 2021 | 109,469 | 109,469 (0%) | 0% | 62.2 | 6,810,066 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges